News

In a retrospective study, researchers from Humana in Louisville, KY, compared clinical outcomes, time on treatment, healthcare resources utilization, and relative costs in patients with MS that were newly initiated on one of the following oral DMTs: dimethyl fumarate, fingolimod, or teriflunomide.

Studies have shown that the use of oral corticosteroids in patients with UC is associated with higher rates of adverse effects and use of healthcare resources compared with biologics or immunosuppressants. However, there is little research focusing on the economic and clinical burden of chronic corticosteroid use among people living with UC.

The company increased its projection for its 2024 medical-benefits to 87.7%.

Republicans voted in favor of a bill that would prohibit the use quality-adjusted life years (QALY) metrics by federal agencies, Medicare Advantage plans and Medicaid managed care organizations. Some patient groups celebrated the passage. Experts have worried that "similar measures" language could stifle all comparative effectiveness analysis.

Patients enrolled in the program had fewer outpatient visits and improved mental health.

On public health, Medicaid and Medicaid managed care, and profit seeking in healthcare.

Obesity affects almost half of adults in the United States.

Historically, health disparities have disproportionately affected underrepresented people with MS, particularly Black and Latinx females.

xCures says artificial intelligence and machine learning can help make sense of disparate medical records.

An estimated 4 million people are living with advanced HIV.

The results of this week’s poll about site-neutral payment extensions.

Given that up to 10% of women have PCOS, results may affect public health at large.

The bulk of Cigna’s revenue comes from Evernorth, which includes the PBM Express Scripts. The company is positioning itself to grow Evernorth even more.

U.S. drug distances were far higher, even when rebates were factored in. The exception is unbranded generics for which prices in the U.S. are lower.

The sale, valued at about $576.5 million, is part of Rite Aid’s restructuring plan after filing for bankruptcy in October 2023.

Should site-neutral payment rules and policies be extended to commercial payers, payment for physician-administered drugs, and services delivered in on-campus hospital outpatient departments?

Study authors hypothesized that factors such as depression, IBD medications, and stomach or rectal surgery may play a role in the increased risk of erectile dysfunction in patients with IBD.

New research finds that in 2022, U.S. prices across all drugs were almost three times higher than in other countries.

Risk also increases with age.

Biogen has stopped its confirmatory trial of Aduhelm and will direct resources toward Leqembi and the research of other treatments for Alzheimer’s disease.

ART-related weight gain is a relatively new phenomenon even though ART has been around for nearly 30 years.

Once the transaction is complete in the first quarter of 2025, Evernorth Health Services will continue to provide pharmacy benefit services to the Medicare businesses.

The report on drug spending touches on the rise of the GLP-1s. hows that As of January, semaglutide was the 5th ranked drug when it came to drug expenditures among Vizient pharmacy partners.

Through investments made by the Bipartisan Safer Communities Act (BSCA), the grants will be awarded to 20 states of up to $2.5 million to support the implementation, improvement and expansion of school-based health services through Medicaid and the Children’s Health Insurance Program (CHIP).

CMS said in a news release today that 13.7 million beneficiaries are in accountable care organizations (ACOs) and that a total of 480 ACOs are participating in the Medicare Shared Savings Program (MSSP).

CVS Caremark, however, will continue to manage specialty drug benefits for Tyson Foods.

Data from 17 longitudinal studies of adults with HIV treated with antiretroviral therapy how that proportion of deaths caused by AIDS has fallen from nearly 50% to 16% and that all-cause mortality has been sliced in half.

Adherent patients accessed services only slightly more.